Creative Planning Bio Affinity Technologies, Inc. Transaction History

Creative Planning

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$1.32 - $2.82 $660 - $1,410	-500 Reduced 3.97%	12,095 $25,000
Q2 2024 Aug 15, 2024	BUY	$1.76 - $3.0 $880 - $1,500	500 Added 4.13%	12,595 $27,000
Q4 2022 Feb 10, 2023	SELL	$1.6 - $3.14 $27,920 - $54,793	-17,450 Reduced 59.06%	12,095 $19,000
Q3 2022 Nov 03, 2022	BUY	$2.11 - $8.3 $62,339 - $245,223	29,545 New	29,545 $86,000

78.7K

Ticker BIAF
Exchange
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 2,727,580
Market Cap $5.02M
Description
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.